Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

CNS 8Gynecologic 7Breast 6Genitourinary 5Gastrointestinal 5Sarcoma 3Other solid neoplasm 3Other hematologic neoplasm 3Lymphoid 3Head & Neck 3Tumor-Agnostic 1Plasma cell 1Other 1Endocrine 1Dermatologic 1

Conditions

Hematologic Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 1Frailty 1

Interventions

Cytarabine 898Cyclophosphamide 893fludarabine 517venetoclax 475fludarabine phosphate 464Azacitidine 451Rituximab 418Methotrexate 414Etoposide 319Filgrastim 299Busulfan 295Dexamethasone 284Vincristine 280Daunorubicin 279Peripheral Blood Stem Cell Transplantation 257Whole-Body Irradiation 240Mycophenolic Acid 231Decitabine 228Granulocyte Colony-Stimulating Factor 225Tacrolimus 219Idarubicin 203Melphalan 201Imatinib Mesylate 195Cyclosporine 182Doxorubicin 176Radiotherapy 169Prednisone 161Mitoxantrone 160Lenalidomide 159Mercaptopurine 154

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Restraint, Physical × Other hematologic neoplasm × Clear all
NCT04888988 2026-04-24

CIPN

University of Rochester

Phase NA Active not recruiting
133 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

NCT05876923 2026-04-09

The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

Mayo Clinic

Phase NA Recruiting
70 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT02359838 2022-07-19

Patient-Centered Care for the Older Adult With Hematologic Malignancy

Dana-Farber Cancer Institute

Phase NA Completed
160 enrolled 7 charts
Other hematologic neoplasm

Frailty, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡